We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer Loses Lyrica Patent Battle in UK Supreme Court
Pfizer Loses Lyrica Patent Battle in UK Supreme Court
Pfizer’s appeal for a second patent on Lyrica (pregabalin) has been denied by the UK’s highest court, ending the pharma giant’s long-running fight against drug companies marketing generic versions of its blockbuster pain treatment.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor